Invesco’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,770
Closed -$95K 4077
2021
Q1
$95K Buy
18,770
+2,273
+14% +$11.8K ﹤0.01% 3765
2020
Q4
$67K Buy
+16,497
New +$81K ﹤0.01% 3706
2020
Q1
Sell
-14,530
Closed -$66K 3759
2019
Q4
$66K Hold
14,530
﹤0.01% 3623
2019
Q3
$60K Buy
+14,530
New +$52.5K ﹤0.01% 3644
2017
Q4
Sell
-16,950
Closed -$67K 3677
2017
Q3
$67K Hold
16,950
﹤0.01% 3622
2017
Q2
$86K Sell
16,950
-5,040
-23% -$28.3K ﹤0.01% 3652
2017
Q1
$152K Buy
+21,990
New +$172K ﹤0.01% 3638
2016
Q4
Sell
-77,939
Closed -$762K 3719
2016
Q3
$762K Sell
77,939
-52,897
-40% -$714K ﹤0.01% 3085
2016
Q2
$1.85M Sell
130,836
-18,439
-12% -$288K ﹤0.01% 2522
2016
Q1
$2.09M Buy
149,275
+23,800
+19% +$349K ﹤0.01% 2445
2015
Q4
$2.56M Buy
+125,475
New +$1.94M ﹤0.01% 2366
2015
Q3
Sell
-327
Closed -$5K 4065
2015
Q2
$5K Buy
+327
New +$6.27K ﹤0.01% 4237

Other funds holding AGTC

Invesco's AGTC Position: Q2 2021 in Review

Invesco sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 18,770 shares — an estimated $95K sold.

Invesco first reported a position in AGTC in Q2 2015 and held it in 12 quarters. The position peaked at $2.56M in Q4 2015. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • Invesco reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • Invesco sold 18,770 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $95K.
  • Invesco first reported a position in Applied Genetic Technologies Corporation in Q2 2015 and held it in 12 quarters.
  • Invesco's Applied Genetic Technologies Corporation position peaked at $2.56M in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.